Peritoneal Dialysis Market

The global Peritoneal Dialysis Market is valued at USD 4.8 Billion in 2023 and is projected to reach a value of USD 8.04 Billion by 2032 at a CAGR (Compound Annual Growth Rate) of 5.91% between 2024 and 2032. The market is driven by increasing prevalence of chronic kidney diseases (CKD) and end-stage renal disease (ESRD) globally.

Key Highlights

• ​Peritoneal dialysis is a medical procedure used to treat patients with kidney failure, where the peritoneum (a membrane lining the abdominal cavity) is used to filter and remove waste products, excess fluids, and toxins from the blood
• Based on the Treatment Type, the Continuous Ambulatory Peritoneal Dialysis (CAPD) accounted for significant market share of 59.2% in 2023
• In 2023, by Product, Peritoneal dialysis devices dominated the market with significant market share of 30.1%
• Home-Based Dialysis dominated the market with market share of 48.2% in 2023
• Asia Pacific dominated the market with 50.5% market share in 2023

Treatment Type Overview

​The Treatment Type segment is divided into Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD). The Continuous Ambulatory Peritoneal Dialysis (CAPD) segment held the dominant share in 2023, accounting for significant market share of 59.2%.

Continuous Ambulatory Peritoneal Dialysis (CAPD) segment’s growth is driven by the rising global patient population. Moreover, the widespread availability of continuous ambulatory peritoneal dialysis (CAPD) machines from leading and emerging vendors is fueling the segment’s market expansion. CAPD is a widely used method for renal replacement therapy in end-stage renal failure (ESRF). Its primary advantages include being cost-effective, quick, and easy to use, not requiring a highly skilled operator, and eliminating the need for anticoagulation.

Product Overview

The Product segment is divided into Peritoneal Dialysis Solution, Peritoneal dialysis devices, Peritoneal dialysis sets, Peritoneal dialysis catheters, Other peritoneal dialysis products. In 2023, the Peritoneal dialysis devices segment held largest share of 30.1% in the Peritoneal Dialysis market.

The peritoneal dialysis devices segment leads the market in 2023, driven by increasing demand for advanced and user-friendly dialysis equipment, particularly automated peritoneal dialysis (APD) devices that enhance patient convenience and improve treatment outcomes. Technological innovations in devices, coupled with the growing adoption of home-based dialysis solutions, have propelled the segment’s dominance in the market.

Regional Overview

In 2023, the Asia Pacific captured 48.2% of the revenue share.

Asia Pacific Peritoneal Dialysis market is driven by a high prevalence of hypertension and growing awareness campaigns about peritoneal dialysis. The region's market growth is also supported by the presence of significant unmet healthcare needs. high prevalence of chronic kidney diseases, including those exacerbated by hypertension and diabetes. Growing access to treatment alternatives and raising awareness of the advantages of peritoneal dialysis are also contributing to the rise, which is being driven by the region's major unmet healthcare demands. The Asia Pacific market is also supported by the government's ongoing initiatives to improve patient access to dialysis treatments and the standard of healthcare facilities. Leading manufacturers are introducing cutting-edge peritoneal dialysis technologies and creative product offers to the region.

North America region is anticipated to grow at the highest CAGR during the forecast period, driven by increasing demand for advanced peritoneal dialysis technologies. Government programs, easier access to goods and services, and the construction of modern medical facilities all contribute to the expansion of market. Leading manufacturers' cutting-edge product launches, strategic mergers & acquisitions, and proactive industry player actions also drives the market in the region. The growing number people living in North America with chronic renal and kidney illnesses is another factor driving market growth.

Based on the provided market data, Vantage Market Research offers customizations in the reports to meet the specific needs of clients.

Key Trends

• Rising Adoption of Home-Based Dialysis: There is increasing demand for home-based peritoneal dialysis due to its convenience, cost-effectiveness, and flexibility for patients compared to in-center hemodialysis
• Technological Advancements: Innovations such as automated peritoneal dialysis (APD) machines, wearable dialysis devices, and improvements in dialysis fluids are enhancing treatment efficiency and patient comfort
• Growing Prevalence of Chronic Kidney Disease (CKD): The rising incidence of CKD, driven by factors such as diabetes and hypertension, is significantly boosting the demand for peritoneal dialysis globally
• Shift Towards Minimally Invasive Treatments: As peritoneal dialysis is less invasive than traditional hemodialysis, patient preference is shifting toward this option, which requires fewer hospital visits and offers greater independence

‹›

Report Coverage & Deliverables

PDF report & online dashboard will help you understand:

• Real-Time Data Updates:
• Competitor Benchmarking
• Market Trends Heatmap
• Custom Research Queries
• Market Sentiment Analysis
• Demographic and Geographic Insights

Book Demo

Get Access Now

Track market trends LIVE & outsmart rivals with our Premium Data Intel Tool: Vantage Point

Market Dynamics

Rising Healthcare Expenditure drives the market

Growth in the market is anticipated due to the growing number of people experiencing renal illnesses, such as kidney failure caused by trauma, diabetes, cancer, and age. The sector is growing because of the many advantages of peritoneal dialysis, which include less expensive than hemodialysis, decreased dietary restrictions, increased mobility, ease of use, and needle-free therapy. Furthermore, the market is further driven by improvements in healthcare infrastructure, the rising popularity of home-based dialysis, and the growing demand for reasonably priced medical equipment.

Lack of Skilled Professionals

Stringent government regulations for approving peritoneal dialysis devices are slowing market growth. Furthermore, a rise in the incidence of technical issues and complications such infections, hernias, and catheter obstructions is anticipated to impede the market. Further limiting the market's growth are the shortage of skilled workers and the limited adoption of peritoneal dialysis cyclers, especially among senior populations.

Rising Number of ESRD Patients Globally

Government initiatives, technological advancements, and awareness programs for chronic kidney disease (CKD) are key factors driving market growth. Health practitioners are increasingly favoring peritoneal dialysis over hemodialysis due to its cost-effectiveness, fewer symptom fluctuations, and greater patient mobility. The market is expanding due to the rising number of people suffering from renal failure as well as the introduction of new products such artificial kidneys and low-maintenance dialysis equipment. In addition, chronic conditions like diabetes and high blood pressure, as well as a lack of kidneys available for transplantation because of stringent rules, are anticipated to propel market expansion in the upcoming years.

Competitive Landscape

The Peritoneal Dialysis market is characterized by the presence of several key players, including Baxter International, Fresenius Medical Care, Medtronic, and B. Braun Melsungen AG, who dominate the market with advanced products and established distribution networks. Additionally, emerging players are introducing new technologies and solutions to improve patient outcomes, further intensifying competition. Strategic collaborations, mergers, acquisitions, and continuous R&D investments are also shaping the competitive dynamics of the market.

The key players in the global Peritoneal Dialysis market include - Medtronic Plc, Terumo Corporation, Newsol Technologies Inc, Renax Biomedical Tech. Co. Ltd, Cook Medical Inc, Utah Medical Products Inc, Fresenius Medical Care AG & Co. KGaA, Poly Medicure Ltd, Medionics International Inc, Baxter International Inc. among others.

Recent Market Developments

• In 2022, Dialyss Pte Ltd was acquired by Nextkidney BV, strengthening its technological capabilities in home hemodialysis

The global Peritoneal Dialysis market can be categorized as Treatment Type, Product, End User and Region.